Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Frequency of Cannabis Use Among Primary Care Patients in Washington State

Gwen T. Lapham, Amy K. Lee, Ryan M. Caldeiro, Dennis McCarty, Kendall C. Browne, Denise D. Walker, Daniel R. Kivlahan and Katharine A. Bradley
The Journal of the American Board of Family Medicine November 2017, 30 (6) 795-805; DOI: https://doi.org/10.3122/jabfm.2017.06.170062
Gwen T. Lapham
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
PhD, MPH, MSW
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy K. Lee
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan M. Caldeiro
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis McCarty
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kendall C. Browne
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise D. Walker
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel R. Kivlahan
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharine A. Bradley
From the Kaiser Permanent Washington Health Research Institute (formerly Group Health Research Institute) (GTL, AKL, KAB); Department of Health Services, University of Washington, Seattle, WA (GTL, KAB); Behavioral Health Support Services, Kaiser Permanente Washington (formerly Group Health Cooperative), Seattle (RMC); Oregon Health & Science University (OHSU) - Portland State University School of Public Health, OHSU, Portland, OR (DM); Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Seattle (KCB, DRK); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (KCB, DRK); Innovative Programs Research Group, School of Social Work, University of Washington, Seattle (DDW); Health Services Research & Development VA Puget Sound Health Care System, Center of Innovation for Veteran-Centered Value-Driven Care, Seattle (DRK); Department of Medicine, University of Washington, Seattle (KAB).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    The prevalence of past-year cannabis use among patients in age and gender subgroups (A) and among those with a documented condition, diagnosis, or behavioral health screen (B). Note, any use is the summed total of monthly/monthly/weekly use and daily use. Documented conditions and diagnoses were in the year before the clinic visit. PHQ-2, Patient Health Questionnaire.

  • Figure 2.
    • Download figure
    • Open in new tab
    Figure 2.

    Among young patients 18 to 29 years old with a documented condition, diagnosis, or positive behavioral health screen, the prevalence and frequency of past-year cannabis Use. PHQ-2, Patient Health Questionnaire.

Tables

  • Figures
    • View popup
    Table 1.

    Diagnostic and Statistical Manual of Mental Disorders-5th Edition (DSM-5) Criteria for a Cannabis Use Disorder

    A problematic pattern of cannabis use leading to clinically significant impairment or distress, as manifested by at least 2 of the following, occurring within a 12-month period
    1. Cannabis is often taken in larger amounts or over a longer period than was intended

    2. There is a persistent desire or unsuccessful efforts to cut down or control cannabis use

    3. A great deal of time is spent in activities necessary to obtain cannabis, use cannabis, or recover from its effects

    4. Craving, or a strong desire or urge to use cannabis

    5. Recurrent cannabis use resulting in a failure to fulfill major role obligations at work, school, or home

    6. Continued cannabis use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of cannabis

    7. Important social, occupational, or recreational activities are given up or reduced because of cannabis use

    8. Recurrent cannabis use in situations in which it is physically hazardous

    9. Cannabis use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by cannabis

    10. Tolerance, as defined by either a (1) need for markedly increased cannabis to achieve intoxication or desired effect, or (2) markedly diminished effect with continued use of the same amount of cannabis

    11. Withdrawal, as manifested by either (1) the characteristic withdrawal syndrome for cannabis, or (2) cannabis is taken to relieve or avoid withdrawal symptoms

    • Note: The severity of a cannabis use disorder is defined as: mild (2 or 3 symptoms), moderate (4 or 5), and severe (6 or more). Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013. All Rights Reserved.

    • View popup
    Table 2.

    Primary Care Adult Patients Who Attended Pilot Sites and Were Screened for Past-Year Cannabis Use (n = 22,095)

    N%
    Sex
        Women13,18259.7
        Men891340.3
    Age categories (years)
        18 to 29222810.1
        30 to 49519423.5
        50 to 64677430.7
        ≥65789935.8
    Race/ethnicity
        Black4902.2
        Hispanic9974.5
        Other19728.9
        White17,99381.4
        Unknown6432.9
        Tobacco use*21339.7
    Diagnoses in prior year*
        Major depression332315.0
        Anxiety disorder299413.6
        Serious mental illness†7043.2
        Alcohol use disorder3961.8
        Cannabis use disorder1090.5
        Other drug use disorder2000.9
    Behavioral health screens
        Depression (PHQ-2)**358216.3
        Unhealthy alcohol use**586326.6
        Any illicit drug use/Rx drug misuse**3631.7
    • ↵* Assessed in the year prior to clinic visit.

    • ↵† Includes diagnoses for bipolar disorder, psychosis, and schizophrenia.

    • ↵** Total N varies due to some patients not completing items of Behavioral Health screen: PHQ-2 (n = 22,081), AUDIT-C (n = 22,034), drug screen (n = 21,945).

    • PHQ-2, Patient Health Questionnaire; AUDIT, Alcohol Use Disorders Identification Test–Consumption.

    • View popup
    Table 3.

    Adjusted* Odds of Any and Daily Past-Year Cannabis Use by Patient Characteristic

    Any UseDaily Use
    Adjusted OR95% CIAdjusted OR95% CI
    Sex
        Women†————
        Men1.68(1.55 to 1.83)§1.87(1.59 to 2.21)§
    Age categories (years)
        18 to 297.34(6.42 to 8.40)§4.82(3.67 to 6.31)§
        30 to 493.26(2.90 to 3.68)§2.75(2.13 to 3.53)§
        50 to 642.61(2.33 to 2.93)§1.92(1.49 to 2.48)§
        ≥65†———— —
    Race
        Black0.68(0.51 to 0.91)¶0.75(0.43 to 1.32)
        Hispanic0.92(0.76 to 1.11)1.09(0.76 to 1.57)
        Other0.71(0.61 to 0.83)§0.70(0.52 to 0.96)¶
        White†————
        Unknown1.00(0.80 to 1.25)1.34(0.91 to 1.97)
    Current tobacco use‡2.00(1.79 to 2.23)§2.92(2.43 to 3.52)§
    Diagnoses in prior year‡
        Major depression1.35(1.20 to 1.52)§1.20(0.96 to 1.49)
        Anxiety disorder1.23(1.09 to 1.38)¶1.23(0.98 to 1.55)
        Serious mental illness1.45(1.18 to 1.79)§1.51(1.05 to 2.17)¶
        Alcohol use disorder0.89(0.69 to 1.16)0.94(0.61 to 1.46)
        Other drug use disorder1.41(0.98 to 2.04)0.94(0.54 to 1.62)
    Behavioral health screens
        Depression (PHQ-2)1.77(1.61 to 1.96)§3.89(3.28 to 4.60)§
        Unhealthy alcohol use2.76(2.54 to 3.00)§1.47(1.24 to 1.74)§
        Any illicit drug use/Rx drug misuse5.19(4.05 to 6.66)§2.86(2.08 to 3.95)§
        Constant0.03(0.03 to 0.03)§0.00(0.00 to 0.01)§
    • ↵* Adjusted for all patient characteristics: sex, age, race, ethnicity, current tobacco use, diagnoses, and behavioral health screens.

    • ↵† Referent group.

    • ↵‡ Assessed in the year prior to clinic visit.

    • ↵§ P-value <.001.

    • ↵¶ P-value <.05.

    • OR, odds ratio; PHQ-2, Patient Health Questionnaire.

    • View popup
    Appendix.

    The Prevalence and Frequency of Past-Year Cannabis Use among Patient Demographic and Behavioral Health Subgroups

    Conditions/Diagnoses in Prior YearBehavioral Health Screens
    Tobacco UseMajor DepressionAnxietySerious Mental IllnessAlcohol Use DisorderOther Drug Use DisorderDepression (PHQ2)Unhealthy Alcohol UseIllicit Drug Use/Rx Misuse
    %95% CI%95% CI%95% CI%95% CI%95% CI%95% CI%95% CI%95% CI%95% CI
    Age 30 to 49 years
        Women(n = 371)(n = 554)(n = 634)(n = 123)(n = 48)(n = 32)(n = 527)(n = 881)(n = 48)
            Any use29.9(25.3 to 34.6)21.8(18.4 to 25.3)22.2(19.0 to 25.5)30.1(21.9 to 38.2)25(12.6 to 37.4)34.4(17.7 to 51.1)28.5(24.6 to 32.3)28.6(25.6 to 31.6)47.9(33.6 to 62.2)
                Frequency of use
                None70.1(65.4 to 74.8)78.2(74.7 to 81.6)77.8(74.5 to 81.0)69.9(61.8 to 78.1)75(62.6 to 87.4)65.6(48.9 to 82.4)71.5(67.7 to 75.4)71.4(68.4 to 74.4)52.1(37.8 to 66.4)
                >Daily19.7(15.6 to 23.7)17(13.8 to 20.1)16.4(13.5 to 19.3)22.8(15.3 to 30.2)18.8(7.6 to 29.9)28.1(12.3 to 44.0)19.5(16.2 to 22.9)25(22.1 to 27.8)37.5(23.7 to 51.4)
                Daily10.2(7.2 to 13.3)4.9(3.1 to 6.7)5.8(4.0 to 7.7)7.3(2.7 to 11.9)6.3(−0.7 to 13.2)6.3(−2.3 to 14.8)8.9(6.5 to 11.4)3.6(2.4 to 4.9)10.4(1.7 to 9.2)
        Men(n = 323)(n = 05)(n = 233)(n = 52)(n = 54)(n = 33)(n = 335)(n = 609)(n = 39)
            Any use36.5(31.3 to 41.8)33.7(27.2 to 40.2)28.8(22.9 to 34.6)36.5(23.3 to 49.8)38.9(25.8 to 52.0)45.5(28.2 to 62.7)37.6(32.4 to 42.8)38.6(34.7 to 42.5)71.8(57.5 to 86.1)
            Frequency of use
                None63.5(58.2 to 68.7)66.3(59.9 to 72.8)71.2(65.4 to 77.1)63.5(50.2 to 76.7)61.1(48.0 to 74.2)54.6(37.3 to 71.8)62.4(57.2 to 67.6)61.4(57.5 to 65.3)28.2(13.9 to 42.5)
                >Daily24.8(20.1 to 29.5)22.4(16.7 to 28.2)19.3(14.2 to 24.4)23.1(11.5 to 34.7)29.6(17.3 to 41.9)21.2(7.0 to 35.4)20.6(16.3 to 24.9)29.4(25.8 to 33.0)41(25.4 to 56.7)
            Daily11.8(8.2 to 15.3)11.2(6.9 to 15.6)9.4(5.7 to 13.2)13.5(4.1 to 22.8)9.3(1.5 to 17.1)24.2(9.4 to 39.1)17(13.0 to 21.1)9.2(6.9 to 11.5)30.8(16.1 to 45.5)
    Age ≥50 years
        Women(n = 628)(n = 1627)(n = 1274)(n = 293)(n = 100)(n = 51)(n = 1306)(n = 2056)(n = 60)
            Any use19.8(16.6 to 22.9)12.9(11.3 to 14.5)13(11.1 to 14.8)11.3(7.6 to 14.9)21(13.0 to 29.0)19.6(8.6 to 30.6)14.9(12.9 to 16.8)14.1(12.6 to 15.6)41.7(29.1 to 54.3)
            Frequency of use
                None80.3(77.1 to 83.4)87.1(85.5 to 88.7)87.1(85.2 to 88.9)88.7(85.1 to 92.4)79(71.0 to 87.0)80.4(69.4 to 91.4)85.2(83.2 to 87.1)85.9(84.4 to 87.4)58.3(45.8 to 70.9)
                >Daily14.7(11.9 to 17.4)10(8.5 to 11.4)10.2(8.5 to 11.9)7.2(4.2 to 10.1)16(8.8 to 23.2)15.7(5.6 to 25.8)9.8(8.2 to 11.4)12.3(10.8 to 13.7)28.3(16.8 to 39.8)
                Daily5.1(3.4 to 6.8)3(2.1 to 3.8)2.8(1.9 to 3.7)4.1(1.8 to 6.4)5(0.7 to 9.3)3.9-(1.5 to 9.3)5.1(3.9 to 6.2)1.9(1.3 to 2.4)13.3(4.7 to 22.0)
        Men(n = 512)(n = 616)(n = 502)(n = 152)(n = 155)(n = 40)(n = 920)(n = 1553)(n = 71)
            Any use27.3(23.5 to 31.2)18.3(15.3 to 21.4)19.5(16.1 to 23.0)19.1(12.8 to 25.4)23.9(17.1 to 30.6)30.0(15.6 to 44.4)20.5(17.9 to 23.2)24.0(21.9 to 26.1)50.7(39.0 to 62.4)
            Frequency of use
                None72.7(68.8 to 76.5)81.7(78.6 to 84.7)80.5(77.0 to 84.0)80.9(74.7 to 87.2)76.1(69.4 to 82.9)70.0(55.6 to 84.4)79.5(76.8 to 82.1)76.0(73.9 to 78.1)49.3(37.6 to 61.0)
                >Daily21.1(17.6 to 24.6)14.8(12.0 to 17.6)15.5(12.4 to 18.7)14.5(8.9 to 20.1)19.4(13.1 to 25.6)25.0(11.4 to 38.6)13.3(11.1 to 15.5)20.2(18.2 to 22.2)36.6(25.3 to 47.9)
                Daily6.3(4.2 to 8.4)3.6(2.1 to 5.0)4.0(2.3 to 5.7)4.6(1.3 to 8.0)4.5(1.2 to 7.8)5.0(−1.8 to 11.8)7.3(5.6 to 9.0)3.8(2.9 to 4.8)14.1(5.9 to 22.2)
    • CI, confidential interval; PHQ-2, Patient Health Questionnaire.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 30 (6)
The Journal of the American Board of Family Medicine
Vol. 30, Issue 6
November-December 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Frequency of Cannabis Use Among Primary Care Patients in Washington State
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Frequency of Cannabis Use Among Primary Care Patients in Washington State
Gwen T. Lapham, Amy K. Lee, Ryan M. Caldeiro, Dennis McCarty, Kendall C. Browne, Denise D. Walker, Daniel R. Kivlahan, Katharine A. Bradley
The Journal of the American Board of Family Medicine Nov 2017, 30 (6) 795-805; DOI: 10.3122/jabfm.2017.06.170062

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Frequency of Cannabis Use Among Primary Care Patients in Washington State
Gwen T. Lapham, Amy K. Lee, Ryan M. Caldeiro, Dennis McCarty, Kendall C. Browne, Denise D. Walker, Daniel R. Kivlahan, Katharine A. Bradley
The Journal of the American Board of Family Medicine Nov 2017, 30 (6) 795-805; DOI: 10.3122/jabfm.2017.06.170062
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Relationship between Cannabis Use and Cognition in People with Bipolar Disorder: A Systematic Scoping Review
  • Multiple Practical Facts and Ideas to Improve Family Medicine Care
  • Google Scholar

More in this TOC Section

  • Identifying and Addressing Social Determinants of Health with an Electronic Health Record
  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
  • A Pilot Comparison of Clinical Data Collection Methods Using Paper, Electronic Health Record Prompt, and a Smartphone Application
Show more Original Research

Similar Articles

Keywords

  • Cannabis
  • Primary Health Care
  • Screening
  • Washington

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire